The board of Tianda Pharmaceuticals Limited announced that Mr. CHIU Fan Wa has tendered resignation as an Independent Non-executive Director with effect from 1 July 2023 as he has decided to devote more time to his personal matters. Mr. CHIU has confirmed that he does not have any disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited. The Board further announces that after the AGM, Dr. XIAN Yanfang has been appointed as an Independent Non-executive Director with effect from 27 June 2023.

Dr. Xian Yanfang, aged 42, is an assistant professor of School of Chinese medicine, The Chinese University of Hong Kong. She has extensive research experience in the field of Pharmacology of Chinese medicines, Herb-drug interactions of Chinese and western medicines and Quality control of Chinese medicines. Dr. Xian is currently a project review expert of National Natural Science Foundation of China, the general secretary of Hong Kong Association of Chinese Herbal Pharmacology, a member of technical support team in Pharmacology and Toxicology of The Hong Kong Government Chinese Medicines Testing Institute, the committee member of Deficiency Syndrome and Geriatrics Professional Committee of China Association of Integrative Medicine, and a member of Branch of Integrative Traditional Chinese and Western Medicine of the China Association of Gerontology and Geriatrics.

Dr. Xian holds a Ph.D degree in Chinese Medicine from The Chinese University of Hong Kong, and a master's degree and a bachelor's degree in Science of Chinese Materia Medica from Guangzhou University of Chinese Medicine. The Board further announces that Dr. XIAN is appointed as a member of each of the audit committee and remuneration committee of the Company following her appointment as Independent Non-executive Director of the Company on 27 June 2023; and Mr. CHIU will cease to be a member of each of the audit committee and remuneration committee of the Company following his resignation as Independent Non-executive Director of the Company on 1 July 2023.